Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-seq of YY1 knockdown and alvocidib treatment in glioblastoma stem cells

ABSTRACT: RNA-seq of YY1 knockdown and alvocidib treatment in glioblastoma stem cells

ORGANISM(S): Homo sapiens

PROVIDER: GSE155836 | GEO | 2022/06/01

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

RNA-seq of YY1 knockdown and alvocidib treatment in glioblastoma stem cells

Project description:RNA-seq of YY1 knockdown and alvocidib treatment in glioblastoma stem cells

| PRJNA655724 | ENA

Bridge Linker-Hi-C (BL-Hi-C) analysis after YY1 knockdown in glioblastoma stem cells

Project description:Bridge Linker-Hi-C (BL-Hi-C) analysis after YY1 knockdown in glioblastoma stem cells

2022-06-01 | GSE155835 | GEO

ChIP-seq of YY1 in glioblastoma stem cells

Project description:ChIP-seq of YY1 in glioblastoma stem cells

2022-06-01 | GSE155834 | GEO

ChIP-seq of YY1 in glioblastoma stem cells

Project description:ChIP-seq of YY1 in glioblastoma stem cells

| PRJNA655727 | ENA

Bridge Linker-Hi-C (BL-Hi-C) analysis after YY1 knockdown in glioblastoma stem cells

Project description:Bridge Linker-Hi-C (BL-Hi-C) analysis after YY1 knockdown in glioblastoma stem cells

| PRJNA655726 | ENA

Glioblastoma stem cells after METTL8 knockdown.

Project description:Glioblastoma stem cells after METTL8 knockdown.

| PRJNA788505 | ENA

Abernathy2016 - glioblastoma treatment

Project description:The paper describes a model of glioblastoma. Created by COPASI 4.25 (Build 207) This model is described in the article: Modeling the Treatment of Glioblastoma Multiforme and Cancer Stem Cells with Ordinary Differential Equations Kristen Abernathy and Jeremy Burke BMC Computational and Mathematical Methods in Medicine Volume 2016, Article ID 1239861, 11 pages Abstract: Despite improvements in cancer therapy and treatments, tumor recurrence is a common event in cancer patients. One explanation of recurrence is that cancer therapy focuses on treatment of tumor cells and does not eradicate cancer stem cells (CSCs). CSCs are postulated to behave similar to normal stem cells in that their role is to maintain homeostasis. That is, when the population of tumor cells is reduced or depleted by treatment, CSCs will repopulate the tumor, causing recurrence. In this paper, we study the application of the CSC Hypothesis to the treatment of glioblastoma multiforme by immunotherapy. We extend the work of Kogan et al. (2008) to incorporate the dynamics of CSCs, prove the existence of a recurrence state, and provide an analysis of possible cancerous states and their dependence on treatment levels. To cite BioModels Database, please use: BioModels Database: An enhanced, curated and annotated resource for published quantitative kinetic models . To the extent possible under law, all copyright and related or neighbouring rights to this encoded model have been dedicated to the public domain worldwide. Please refer to CC0 Public Domain Dedication for more information.

2024-09-02 | BIOMD0000000757 | BioModels

Glioblastoma stem cells after treatment with sulconazole.

Project description:Glioblastoma stem cells after treatment with sulconazole.

| PRJNA628508 | ENA

RNA-seq of glioblastoma stem cells with shRNA-mediated CCR7 knockdown

Project description:RNA-seq of glioblastoma stem cells with shRNA-mediated CCR7 knockdown

2023-08-04 | GSE218042 | GEO

Gene expression profiles in SATB2-knockdown and control human glioblastoma stem cells

Project description:Effects of SATB2 knockdown on gene expression were evaluated by microarray analysis in human glioblastoma stem cells

2020-09-12 | GSE154789 | GEO